When it sounds too wild to be true, it’s likely a plot put into place by the U.S. military. Such is the case with one of their latest plans, researching an anti-aging pill. U.S. Special Operations Command, or SOCOM, recently stated that they are researching a pill that could help pause some natural aging processes.
The thought of anti-aging technology is nothing new. It’s an idea that’s graced books and the big screen alike with fancy medicines or machines that were seemingly a cure-all. Of course, those were all fictional. But in real life, skin-care products of all kinds boast anti-aging abilities, as do particular diets. However, this is likely the first time we’ve seen something to this degree, or on this scale. Let alone put forth by the U.S. military.
The anti-aging pill’s research
After years of clinical and trials researching safety precautions, SOCOM plans to start “performance testing” for the fiscal year 2022, a spokesperson recently announced. They are partnering with a private firm, Metro International Biochem, a biotech lab company out of Michigan.
Consisting of a literal pill, the goal is to add human performance to the body, enhancing the body’s natural ability to heal itself. Essentially, they are focusing on a “human performance small molecule” and turning it into a “nutraceutical form,” according to the spokesperson, Navy Commander Tim Hawkins.
“These efforts are not about creating physical traits that don’t already exist naturally. This is about enhancing the mission readiness of our forces by improving performance characteristics that typically decline with age. Essentially, we are working with leading industry partners and clinical research institutions to develop a nutraceutical, in the form of a pill that is suitable for a variety of uses by both civilians and military members, whose resulting benefits may include improved human performance — like increased endurance and faster recovery from injury,” he said.
How it works
The molecule is said to be nicotinamide adenine dinucleotide (NAD+). The research has shown that a reduction in NAD+ is shown in many aging-based diseases or ailments.
At this time, nutraceuticals are not regulated by the FDA. The pill, once regulated, is planned to be available for military members and civilians alike.
Other announcements mirrored the above, stating that the pill is meant to help prevent injuries, especially as people get further in age. Some preventable injuries include loss of eyesight and blindness, cramps and muscle weakness, diabetes, intestinal issues, liver failure, problems with the kidneys, certain heart conditions and nervous system diseases, such as dementia, strokes, seizures and spasms.
This testing and research has been going on since 2018. In total, about $2.8 million has gone into biotechnology data and studies and the potential effects of NAD+.
The results of the upcoming trial will determine SOCOM’s next moves for their pill. To learn more about the upcoming trial and any potential availability with the military’s anti-aging pill, follow their progress on SOCOM’s website, or by following Metro International’s website.